7.230SEK+6.32%Mkt Cap: 302.42M $P/E: —Today
Egetis Therapeutics AB (publ), a pharmaceutical company, engages in the development and commercialization of orphan drugs in Sweden and internationally. It develops Aladote, which is in Phase IIb/III clinical trial for t…
Industry Peers
Biotechnology$130.23BUSDP/E 32.1
$139.84BUSDP/E 32.2
$85.11BUSDP/E 20.4
$69.62BUSD
$60.19BUSDP/E 39.1
$45.16BUSDP/E 19.2
$46.01BUSD
$41.76BUSDP/E 66.2
$35.67BUSDP/E 33.2
$32.46BUSDP/E 42.3
$28.53BUSD
$26.14BUSD
$25.79BUSDP/E 16.2
$20.83BUSDP/E 26.3
$19.17BUSDP/E 26.2
$17.03BUSDP/E 20.0
$16.41BUSD
$13.48BUSDP/E 17.1
$13.42BUSDP/E 187.4
$12.87BUSDP/E 264.5
Key Statistics
Company
Market Cap302.42M $
Enterprise Value250.59M $
Revenue (TTM)6.04M $
Gross Profit1.19M $
Net Income (TTM)-32.76M $
Revenue/Share0.0160 USD
Last Price7.230 SEK
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees44
CountrySE
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)58.83
PEG—
EV/EBITDA-7.49
EV/Revenue41.52
P/S52.02
P/B11.22
EPS (TTM)-0.90
EPS (Forward)0.12
52W Range
3.62599% of range7.280
52W High7.280 SEK
52W Low3.625 SEK
Profitability
Gross Margin19.87%
Oper. Margin-693.28%
EBITDA Margin0.00%
Profit Margin-548.88%
ROE-101.15%
ROA-53.59%
Growth
Revenue Growth5.50%
Earnings Growth—
Cash Flow & Leverage
Operating CF-25.54M $
CapEx (TTM)143.48K $
FCF Margin-201.23%
FCF Yield-4.02%
Net Debt-6.44M $
Net Debt/EBITDA0.19
Balance Sheet
Debt/Equity0.27
Current Ratio0.69
Quick Ratio0.65
Book Value/Sh0.6290 SEK
Cash/Share0.3610 SEK
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 SEK
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating2.0 (Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)15.33 SEK
Upside (mean)+112.1%
Target Range11.00 SEK – 23.00 SEK
SEK11.00+112.1% to meanSEK23.00
# Analysts3
Ownership
Shares Out.464.95M
Float204.04M
Insiders23.39%
Institutions52.31%
Technical
SMA 506.200 (+16.6%)
SMA 2005.578 (+29.6%)
Beta0.78
S&P 52W Chg18.16%
Avg Vol (30d)597.31K
Avg Vol (10d)683.10K
Technical Indicators
RSI (14)55.1
MACD0.2270
MACD Signal0.2249
MACD Hist.+0.0021
BB Upper7.433 SEK
BB Middle6.702 SEK
BB Lower5.970 SEK
BB Width21.84%
ATR (14)0.2872 SEK
Vol Ratio (20d)0.84x